Pershing Square Sohn Cancer Prize
The Pershing Square Sohn Cancer Prize funds early-career U.S. scientists to pursue bold, high-risk cancer research and supports them with networking and industry collaborations.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): November 2026 (Letter of Intent deadline, projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years); minimum of 6 awards per cycle
Summary: Supports early-career U.S. scientists with bold, high-risk cancer research through substantial funding and networking opportunities.
Key Information: Now open to all U.S. institutions; only one application per PI per year and max two attempts per PI.
Description
The Pershing Square Sohn Cancer Prize is an annual award from the Pershing Square Sohn Cancer Research Alliance that empowers early-career scientists in the United States to pursue innovative, high-risk cancer research. The program aims to accelerate cures for cancer by providing substantial funding at a stage when traditional support may be unavailable, and by fostering collaborations between the scientific and business communities. In addition to financial support, recipients gain access to an extensive network, industry partnerships, and platforms to present their work, all designed to help translate bold scientific ideas into impactful cancer therapies.
